A recent study in MND indicated that raised peripherin was detectable in the blood of patients with MND using a commercial ELISA, but three orders of magnitude (>1000 times) higher than what we report.9 Future studies might consider a method comparison approach using Bland-Altman plots. This evidence concerns the gene PRPH and mild neurocognitive disorder.